Chester S. Zygmont III - Feb 11, 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Financial Officer
Signature
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont III
Stock symbol
REVB
Transactions as of
Feb 11, 2025
Transactions value $
$58,236
Form type
4
Date filed
2/13/2025, 06:05 PM
Previous filing
Feb 28, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $58.2K +15K +53742.86% $3.87 15.1K Feb 11, 2025 By Trust F1, F2
holding REVB Common Stock 28 Feb 11, 2025 By Trust F2
holding REVB Common Stock 13 Feb 11, 2025 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.
F2 Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
F3 Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.